Advanced Medical Solutions Group plc (AIM:AMS)

Market Cap	461.88M
Revenue (ttm)	131.11M
Net Income (ttm)	11.13M
Shares Out	217.87M
EPS (ttm)	0.05
PE Ratio	41.49
Forward PE	17.58
Dividend	0.02 (1.15%)
Ex-Dividend Date	Sep 26, 2024

Volume	244,478
Average Volume	678,991
Open	210.00
Previous Close	212.00
Day's Range	210.58 - 216.00
52-Week Range	176.60 - 275.83
Beta	0.71
RSI	49.97
Earnings Date	Mar 19, 2025

About AIM:AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names. It also provides wound car...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 850
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2023, AIM:AMS's revenue was 126.21 million, an increase of 1.51% compared to the previous year's 124.33 million. Earnings were 15.89 million, a decrease of -22.14%.